Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court

A case involving access to mifepristone is currently before the Supreme Court. The case, Louisiana v. FDA, is part of a larger landscape of pending litigation related to the medication. The issue is tied to a broader tension between states with differing approaches to abortion. Some states are working to protect access to abortion, while others are seeking to ban the provision of abortion services. Further details about the case and related litigation can be found through the KFF Women's Health Policy, which provides an overview of the current situation and the ongoing legal developments surrounding mifepristone.